+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Momenta Pharmaceuticals Inc - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 39 Pages
  • December 2021
  • GlobalData
  • ID: 5519771
Momenta Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope


  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The publisher’s summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights


Momenta Pharmaceuticals Inc (Momenta) is a biotechnology company which specializes in the structural analysis, characterization, and design of complex pharmaceuticals. The company’s marketed products include Glatopa and Enoxaparin Sodium Injection. Its pipeline portfolio includes biosimilar as well its own novel product candidates. The company utilizes its technology such as Sialylation platform and SIFbody platform for developing generic versions, biosimilars, complex drugs, and potentially interchangeable biologics, and also in the discovery and development of therapeutics for various cancers and autoimmune indications. The company markets its products through its collaborative partners. Momenta is headquartered in Cambridge, Massachusetts, the US.

Momenta Pharmaceuticals Inc Key Recent Developments


Aug 20,2020: J&J to buy Momenta Pharmaceuticals for $6.5bn
Aug 10,2020: Momenta Pharmaceuticals reports second quarter 2020 financial and operating results
May 07,2020: Momenta Pharmaceuticals reports first quarter 2020 financial and operating results
Apr 02,2020: Momenta provides corporate update amid COVID-19 pandemic
Feb 26,2020: Momenta Pharmaceuticals reports fourth quarter and full year 2019 financial results

Reasons to Buy


  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the publisher’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Momenta Pharmaceuticals Inc - Key Facts
  • Momenta Pharmaceuticals Inc - Key Employees
  • Momenta Pharmaceuticals Inc - Key Employee Biographies
  • Momenta Pharmaceuticals Inc - Major Products and Services
  • Momenta Pharmaceuticals Inc - History
  • Momenta Pharmaceuticals Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries

Section 2 - Company Analysis
  • Company Overview
  • Momenta Pharmaceuticals Inc - Business Description
  • Momenta Pharmaceuticals Inc - Corporate Strategy
  • Momenta Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Momenta Pharmaceuticals Inc - Strengths
  • Momenta Pharmaceuticals Inc - Weaknesses
  • Momenta Pharmaceuticals Inc - Opportunities
  • Momenta Pharmaceuticals Inc - Threats
  • Momenta Pharmaceuticals Inc - Key Competitors

Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Momenta Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Momenta Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • Momenta Pharmaceuticals Inc, Recent Deals Summary

Section 4 - Company’s Recent Developments
Aug 20, 2020: J&J to buy Momenta Pharmaceuticals for $6.5bn
Aug 10, 2020: Momenta Pharmaceuticals reports second quarter 2020 financial and operating results
May 07, 2020: Momenta Pharmaceuticals reports first quarter 2020 financial and operating results
Apr 02, 2020: Momenta provides corporate update amid COVID-19 pandemic
Feb 26, 2020: Momenta Pharmaceuticals reports fourth quarter and full year 2019 financial results
Jan 13, 2020: Momenta provides year-end 2019 update and 2020 outlook
Jan 03, 2020: Momenta Pharmaceuticals announces CFO transition
Section 5 - Appendix
  • Methodology
  • About The Publisher
  • Contact The Publisher
  • Disclaimer

List of Tables
  • Momenta Pharmaceuticals Inc, Key Facts
  • Momenta Pharmaceuticals Inc, Key Employees
  • Momenta Pharmaceuticals Inc, Key Employee Biographies
  • Momenta Pharmaceuticals Inc, Major Products and Services
  • Momenta Pharmaceuticals Inc, History
  • Momenta Pharmaceuticals Inc, Subsidiaries
  • Momenta Pharmaceuticals Inc, Key Competitors
  • Momenta Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Momenta Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • Momenta Pharmaceuticals Inc, Recent Deals Summary

List of Figures
  • Momenta Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Momenta Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Viela Bio Inc
  • Teva Pharmaceutical Industries Ltd
  • Synthon Pharmaceuticals Inc
  • Sanofi
  • Innovent Biologics Inc
  • EMD Serono Inc
  • Coherus BioSciences Inc
  • Biogen Inc
  • Biocad
  • Amgen Inc
  • AB Biosciences Inc